M. Elizabeth Hammond

Author

Also Known As

Donald B. Doty, M E Hammond, M Elizabeth H Hammond, M Elizabeth Hammond, M Hammond, M. E. H. Hammond, M. E. Hammond, M. ELIZABETH HAMMOND, M. Elizabeth H. Hammond, M. Elizabeth Hale Hammond

Publications

15.6K

Citations

H-Index

113

Concepts

All Affiliations

University of Utah Massachusetts General Hospital Harvard University Intermountain Healthcare Johns Hopkins University

About

M. Elizabeth Hammond is an author at University of Utah specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	5.2K
2	Health Sciences	2	2	106
3	Engineering	1	1	42
4	Natural Sciences	1	1	14
5	Public Health	1	1	48

M. Elizabeth Hammond

Publications

13.6K

Citations

H-Index

Page 1

	Year	Citations
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Journal of Clinical Oncology	2013	4K
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Journal of Clinical Oncology Tumor BiologyBreast Cancer GuidelineBreast OncologyClinical Oncology/collegeCancer Detection	2018	2.3K
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Archives of Pathology & Laboratory Medicine	2013	1.8K
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. Margaret E. Billingham, N. Cary, M. Elizabeth Hammond, PubMed Lung TransplantationHeart FailureTransplantationTransplantation MedicineDiagnosis	1991	1.5K
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Archives of Pathology & Laboratory Medicine	2018	1.4K
IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors M. Elizabeth Hammond, Gena Lapointe, Paul Feucht, The Journal of Immunology	1995	372
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update Ian E. Krop, Nofisat Ismaila, Fabrice André, Journal of Clinical Oncology Prognostic BiomarkersNode-negative Breast CancerBreast OncologyMedicineCancer Management	2017	312
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology Phillip G. Febbo, Marc Ladanyi, Kenneth Aldape, Journal of the National Comprehensive Cancer Network Nccn Task ForceCancer ManagementPathologyBiomarker TestingGlioma	2011	253
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx Fabrice André, Nofisat Ismaila, N. Lynn Henry, Journal of Clinical Oncology	2019	227
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer Mary McCormack, Latha Kadalayil, Allan Hackshaw, British Journal of Cancer	2013	119

Page 1